Bai Lilian, Guo Yanyan, Gong Junxing, Li Yuchen, Huang Hefeng, Meng Yicong, Liu Xinmei
Shanghai Key Laboratory of Embryo Original Diseases, The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Obstetrics and Gynecology Hospital, Institute of Reproduction and Development, Fudan University, Shanghai, China.
Front Physiol. 2023 Jun 13;14:1078166. doi: 10.3389/fphys.2023.1078166. eCollection 2023.
Preeclampsia is a disease that affects both the mother and child, with serious consequences. Screening the characteristic genes of preeclampsia and studying the placental immune microenvironment are expected to explore specific methods for the treatment of preeclampsia and gain an in-depth understanding of the pathological mechanism of preeclampsia. We screened for differential genes in preeclampsia by using limma package. Gene Ontology, Kyoto Encyclopedia of Genes and Genomes, disease ontology enrichment, and gene set enrichment analyses were performed. Analysis and identification of preeclampsia biomarkers were performed by using the least absolute shrinkage and selection operator regression model, support vector machine recursive feature elimination, and random forest algorithm. The CIBERSORT algorithm was used to analyze immune cell infiltration. The characteristic genes were verified by RT-qPCR. We identified 73 differential genes, which mainly involved in reproductive structure and system development, hormone transport, etc. KEGG analysis revealed emphasis on cytokine-cytokine receptor interactions and interleukin-17 signaling pathways. Differentially expressed genes were dominantly concentrated in endocrine system diseases and reproductive system diseases. Our findings suggest that , and can be used as placental markers for preeclampsia and they are associated with various immune cells. The differentially expressed genes in preeclampsia are related to inflammatory response and other pathways. Characteristic genes, , and can be used as diagnostic and therapeutic targets for preeclampsia, and they are associated with immune cell infiltration. Our findings contribute to the pathophysiological mechanism exploration of preeclampsia. In the future, the sample size needs to be expanded for data analysis and validation, and the immune cells need to be further validated.
子痫前期是一种影响母婴的疾病,后果严重。筛查子痫前期的特征基因并研究胎盘免疫微环境,有望探索子痫前期的特异性治疗方法,并深入了解子痫前期的病理机制。我们使用limma软件包筛选子痫前期中的差异基因。进行了基因本体论、京都基因与基因组百科全书、疾病本体论富集和基因集富集分析。使用最小绝对收缩和选择算子回归模型、支持向量机递归特征消除和随机森林算法进行子痫前期生物标志物的分析和鉴定。使用CIBERSORT算法分析免疫细胞浸润。通过RT-qPCR验证特征基因。我们鉴定出73个差异基因,主要涉及生殖结构和系统发育、激素转运等。KEGG分析显示重点在于细胞因子-细胞因子受体相互作用和白细胞介素-17信号通路。差异表达基因主要集中在内分泌系统疾病和生殖系统疾病中。我们的研究结果表明,[此处原文缺失具体基因名称]、[此处原文缺失具体基因名称]和[此处原文缺失具体基因名称]可作为子痫前期的胎盘标志物,且它们与多种免疫细胞相关。子痫前期中差异表达的基因与炎症反应和其他通路有关。特征基因[此处原文缺失具体基因名称]、[此处原文缺失具体基因名称]和[此处原文缺失具体基因名称]可作为子痫前期的诊断和治疗靶点,且它们与免疫细胞浸润相关。我们的研究结果有助于子痫前期病理生理机制的探索。未来,需要扩大样本量进行数据分析和验证,并且需要进一步验证免疫细胞。